Keywords
coronary artery bypass surgery(CABS)
myocardial protection
How to Cite
Abstract
Introduction: Ischemic preconditioning (IP) is a method that may help protect the human heart from injury during cardiac surgery. It is believed that IP prepares the heart for upcoming prolonged ischemia by activating local protective mechanisms.
Objective: This prospective study aims to evaluate the degree of myocardial protection offered by IP compared to standard cold blood cardioplegia (CBC).
Materials and Methods: Fifty patients with stable angina and coronary artery disease (CAD) scheduled for coronary artery bypass grafting (CABG) were randomized into two groups: IP (n=25) and control (n=25). In the IP group, two cycles of 2-minute ischemia followed by 3-minute reperfusion were applied before aortic cross-clamping. Blood samples were collected through a central venous catheter to measure creatine kinase-MB fraction (CK-MB), creatine phosphokinase (CPK), cardiac troponin I (cTnI), and lactate dehydrogenase (LDH). Postoperative cardiac rhythm was also monitored.
Results: The release of cTnI and lactate was significantly lower in the IP group compared to the control group (cTnI p < 0.0001, CK-MB p = 0.005, CPK p = 0.005). However, there was no significant difference in LDH levels between the groups (p = 0.264). The need for defibrillation after cardiac arrest was lower in the IP group compared to the control group (18% vs. 40%).
Conclusion: The role of IP in cardiac surgery remains uncertain. However, compared to CBC alone in low-risk CABG patients, IP as an adjunct to CBC reduced levels of cTnI, CK-MB, and CPK, and was associated with a lower incidence of postoperative atrial fibrillation.
References
Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med. 2007; 357:1121–35.
Schott RJ, Rohmann S, Braun ER, Schaper W. Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res. 1990; 66:1133–42.
Li GC, Vasquez JA, Gallagher KP, Lucchesi BR. Myocardial protection with preconditioning. Circulation. 1990; 82:609–19.
Lu EX, Chen SX, Yuan MD, Hu HT, Zhou HC, Luo WJ, et al. Preconditioning enhances myocardial protection in patients undergoing open-heart surgery. Ann Thorac Surg. 1997;64(5):1320–4.
Galinanes M, Argano V, Hearse DJ. Can ischemic preconditioning ensure optimal myocardial protection when delivery of cardioplegia is impaired? Circulation. 1995;92(Suppl II): II389–94.
Vaage J, Valen G. Pathophysiology and mediators of ischemia-reperfusion injury with special reference to cardiac surgery: A review. Scand J Thorac Cardiovasc Surg Suppl. 1993; 41:1–18.
Opie LH. Myocardial ischemia: Metabolic pathways and implications of increased glycolysis. Cardiovasc Drug Ther. 1990;4(Suppl 4):777–90.
Partington MT, Acar C, Buckberg GD, Julia PL. Studies of retrograde cardioplegia. II. Advantages of antegrade/retrograde cardioplegia to optimize distribution in jeopardized myocardium. J Thorac Cardiovasc Surg. 1989; 97:613–22.
Partington MT, Acar C, Buckberg GD, Julia P, Kofsky ER, Bugyi G. Studies of retrograde cardioplegia. I. Capillary blood flow distribution to myocardium supplied by open and occluded arteries. J Thorac Cardiovasc Surg. 1989; 97:605–12.
Januzzi JL, Lewandrowski K, MacGillivray TE, Newell JB, Kathiresan S, Servoss SJ, et al. A comparison of cardiac troponin T and creatine kinase-MB for patient evaluation after cardiac surgery. J Am Coll Cardiol. 2002; 39(9):1518–23.
Muehlschlegel JD, Perry TE, Liu KY, Nascimben L, Fox AA, Collard CD, et al. Troponin is superior to electrocardiogram and creatinine kinase-MB for predicting clinically significant myocardial injury after coronary artery bypass grafting. Eur Heart J. 2009; 30(13):1574–83.
Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction. J Am Coll Cardiol. 2018; 72(18):2231–64.
Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation. 1986; 74(5):1124–36.
Yellon DM, Downey JM. Preconditioning the myocardium: From cellular physiology to clinical cardiology. Physiol Rev. 2003; 83(4):1113–51.
Bingyang J, Mingzheng L, Jinping L, Guyan W, Wei F, Feng L. Evaluation by cardiac troponin I: The effect of ischemic preconditioning as an adjunct to intermittent blood cardioplegia on coronary artery bypass grafting. J Card Surg. 2007; 22:394–400.
Teoh LKK, Grant R, Hulf JA, Pugsley WB, Yellon DM. The effect of preconditioning (ischemic and pharmacological) on myocardial necrosis following coronary artery bypass graft surgery. Cardiovasc Res. 2002; 53:175–80.
Lomivorotov VV, Shmyrev VA, Nepomnyaschih VA, Ponomarev DN, Knyazkova LG, Lomivorotov VN, et al. Remote ischemic preconditioning does not protect the heart in patients undergoing coronary artery bypass grafting. Interact Cardiovasc Thorac Surg. 2012;15(1):18–22.
Pell TJ, Baxter GF, Yellon DM, Drew GM. Renal ischemia preconditions myocardium: Role of adenosine receptors and ATP-sensitive potassium channels. Am J Physiol. 1998;275(5 Pt 2):H 1542–7.
Heuts S, Denessen EJS, Daemen JHT, Vroemen WHM, Sels JW, Segers P, et al. Meta-analysis evaluating high-sensitivity cardiac troponin T kinetics after coronary artery bypass grafting in relation to the current definitions of myocardial infarction. Am J Cardiol. 2022;163:25–31.
Hu S, Dong HL, Li YZ, Luo ZJ, Sun L, Yang QZ, et al. Effects of remote ischemic preconditioning on biochemical markers and neurologic outcomes in patients undergoing elective cervical decompression surgery: A prospective randomized controlled trial. J Neurosurg Anesthesiol. 2010; 22(1):46–52.
Pehkonen EJ, Rinne TT, Mäkynen PJ, Kaukinen SK, Tarka MR. Conduction disturbances after blood and crystalloid cardioplegia in coronary bypass surgery. Scand J Thorac Cardiovasc Surg. 1993; 27:143–7.
Pehkonen EJ, Reinikainen PM, Kataja MJ, Tarka MR. Rhythm disturbances after blood and crystalloid cardioplegia in coronary artery bypass grafting. Scand J Thorac Cardiovasc Surg. 1995; 29:23–8.
Pires LA, Wagshal AB, Lancey R, Huang SK. Arrhythmias and conduction disturbances after coronary artery bypass graft surgery: Epidemiology, management, and prognosis. Am Heart J. 1995; 129:799–808.
Deng QW, Xia ZQ, Qiu YX, Wu Y, Liu JX, Li C, et al. Clinical benefits of aortic cross-clamping versus limb remote ischemic preconditioning in coronary artery bypass grafting with cardiopulmonary bypass: A meta-analysis of randomized controlled trials. J Surg Res. 2015;193:52–8.
Przyklenk K. Reduction of myocardial infarct size with ischemic “conditioning”: Physiologic and technical considerations. Anesth Analg. 2013; 117:891–901.